DERAMAXX 25MG CHEWABLE TABLETS FOR DOGS

Land: Australia

Språk: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiv ingrediens:

DERACOXIB

Tilgjengelig fra:

ELANCO AUSTRALASIA PTY LTD

INN (International Name):

deracoxib(25mg/Tb)

Legemiddelform:

ORAL BOLUS, CHEWABLE

Sammensetning:

DERACOXIB ANTI-INFLAMMATORY-NON-STEROIDA Active 25.0 mg/Tb

Enheter i pakken:

30 Tablets; 7 Tablets; 90 Tablets

Klasse:

VM - Veterinary Medicine

Produsert av:

ELANCO AUSTRALASIA

Terapeutisk gruppe:

DOG | BITCH | CASTRATE | PUPPY

Terapeutisk område:

MUSCULOSKELETAL SYSTEM

Indikasjoner:

ANALGESIC | MUSCOSKELETAL DISCOMFORT | MUSCULOSKELETAL CONDITIONS | ORTHOPAEDIC - INFLAMATION | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BURSITIS | COLIC | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATION | MUSCLE RELAXANT | OSTEITIS | OSTEOARTHRITIS | PAIN | SEDATIVE | SPASMOLYTIC | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE

Produkt oppsummering:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANALGESIC, MUSCOSKELETAL DISCOMFORT, MUSCULOSKELETAL CONDITIONS, ORTHOPAEDIC - INFLAMATION]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANALGESIC, MUSCOSKELETAL DISCOMFORT, MUSCULOSKELETAL CONDITIONS, ORTHOPAEDIC - INFLAMATION]; For control of pain and inflammation associated with osteoarthritis and orthopaedic surgery in dogs.Contraindicated for use in cats. See CONTRAINDICATIONS, PRECAUTIONS & SIDE EFFECTS on label also.

Autorisasjon status:

Stopped

Autorisasjon dato:

2023-07-01

Informasjon til brukeren

N
0
0
_?ft. _
11111111111111
9
11
326895
002341
11
>
APVMA
Approval
No.
58695/7T
/1
006
NOV
ARTIS
Animal
Health
Australasia
Pty
Limited
ACVM
No.A9600
P.A.R.
Class
I
Novartis
New
Zealand
Ltd.
3666-11-06A
Store
below
30°(
(Room
Temperature).
~
"""'
!;r
N
"'T'I
n
U1
_Q _
:::r
3
~g.S'
\0
~~~!:!:n
::::r
C!.
0
~
:::r
.g~an
tD
Z....,.
~c...ma
o
::E
·~
-
::II
D.J
_0 _
-I
e::eo--
,.,
n
-·-Ill
..,
.......
-
"'
.-+-c
-·
-
.......,
C'"
~::::
::::rcu
::II
tD
..,.,_
-
.....
o
s·
"'
,_.
tD
~
:a_
cu
N
_";t _
:;o
(ri
-<
~
::::s
U1
_cr _
.......]
-·
QJ
c...
3
...,
::::s
::::a.
s·
tD"
c...
=r::::!:!
I.CI
-
-
v:l
0
;::::;:
QJ
c
"'
~
v;·3
m
-h
.
0
3
~
_0 _
.....
QJr#'
...
!::::!".n
C
g
~
_0 _
-
\0
CICI
lin
"'
~
a
=
;IIIII;
"''"'m.,
om
::a
::a.,~
>On
zc:::a
_
.....
:;;
:s:::o
.....
>"''"'s
r-::az
==~>
mnz
!t:z:i:
3:0>
m"'~"~r-
zn::a
.....
:Z:m
or=:s:
zCm
!<~5!
z
READ
THE
ATTACHED
LEAFLET
BEFORE
USING
THIS
PRODUCT
DIRECTIONS
FOR
USE
DERAMAXXTablets
should
be
given
by
mouth,
with
or
without
food.
The
tablets
are
half-scored
for
more
flexible
dosing.
The
recommended
dose
rate
should
not
be
exceeded.
For
control
of
pain
and
inflammation
associated
with
osteoarthritis:
The
recommended
dose
rate
is
1-2
mg/kg
bodyweight
once
daily.
For
control
of
pain
and
inflammation
associated
with
orthopaedic
surgery:
The
recommended
dose
rate
is
3-4
mg/kg
bodyweight
once
daily
for
7
days.
The
attached
leaflet
describes
directions
for
use
and
precautions
to
follow
when
administering
DERAMAXX
Tablets.
Dispose
of
empty
containers
by
wrapping
in
paper
and
putting
in
garbage.
c.::::>
-·o
~::::>
5'-c
CD
:::::::!.
a:
::::>
co
_w _
C)
......
u,:.,.
_...... _
w----~
,...._
____
1\.J-...j
3u:!
2,"
Jl
~~~~llll~~~~~
1,111
APVMAApproval
N~
58695nl/1006
NOV
ARTIS
Animal
Health
Australasia
Pty
Limited
ACVM
No.A9600
PAR.
Closs
I
Novartis
New
Zealand
Lid.
3666·11·06A
Store
below
30"C
(Room
Temperature).
5I
...
~
...
...
om::a
~
=-;;C~
Qi
j;sQ
:!1
!!:o:!l
=
iii
~i!
~~;
m"".-
zn00
®
.....
:!:m
.....
!!:
Z"'m
tegjSI
0
0
C)
1\.J
(1'1
.
C')
;:Il
~
.
_w _
1\.J•
(

Preparatomtale

 
  PRODUCT NAME: DERAMAXX
®
 25 MG CHEWABLE TABLETS FOR DOGS 

                 PAGE NO: 
1 OF 3 

                 DATE OF ISSUE:  NOVEMBER 2008 

MATERIAL SAFETY DATA SHEET 
Novartis Animal Health Australasia Pty Ltd 

SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY 
COMPANY DETAILS: 
NOVARTIS ANIMAL HEALTH AUSTRALASIA PTY LIMITED 
PHONE: (02)  9805 3555 
A.C.N. 076 745 198  
FAX:      (02)  9888 8387 
54 WATERLOO ROAD 

NORTH RYDE NSW 2113 

PRODUCT NAME:               
Deramaxx
®
 25 mg Chewable Tablets for Dogs 
ACTIVE INGREDIENTS:  

Deracoxib 
PRODUCT USE:  

For the control of pain and inflammation associated with
osteoarthritis or 
orthopaedic surgery in dogs. 
REVISION DATE:     

November 2008 
SECTION 2    HAZARDS IDENTIFICATION 
HAZARD CLASSIFICATION:        
Hazardous Substance 
Non-Dangerous Goods 
RISK PHRASES:                      
None 
SAFETY PHRASES:                   
None 
SUSDP CLASSIFICATION:       
4 
UN NUMBER:                       
None Allocated 
SECTION 3   COMPOSITION / INFORMATION ON INGREDIENTS 
INGREDIENTS CAS 
NO. 
CONTENT 
(MG/TABLET) 
Deracoxib [169590-41-4] 
25 
other ingredients determined not to be hazardous 
 - 
up to 500 

This is a commercial product whose exact ratio of components may
vary slightly. Minor quantities of other 
non hazardous ingredients are also possible. 
SECTION 4   FIRST AID MEASURES 
LABEL REGULATED FIRST  
AID STATEMENT:                      
If poisoning occurs contact a doctor or Poisons Information
Centre 
(Phone 13 1126).  
SCHEDULED POISONS :           
Product is an S
4
 scheduled poison. Poisons Information Ce